Nothing Special   »   [go: up one dir, main page]

PH22805A - Stabilization of interferons - Google Patents

Stabilization of interferons

Info

Publication number
PH22805A
PH22805A PH34356A PH34356A PH22805A PH 22805 A PH22805 A PH 22805A PH 34356 A PH34356 A PH 34356A PH 34356 A PH34356 A PH 34356A PH 22805 A PH22805 A PH 22805A
Authority
PH
Philippines
Prior art keywords
mmol
stabilization
interferons
polyphosphate
guarantees
Prior art date
Application number
PH34356A
Inventor
Gallati Dr Harald
Pracht Inge
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH22805A publication Critical patent/PH22805A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/217IFN-gamma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE A composition containing interferon, a phosphate buffer system, which guarantees a pH value of 6.0-9.0, preferably of 7.5, and which has a phosphate concentration of 500-1000 mmol/l, preferably 1000 mmol/l, and/or polyphosphate. 1. Claims for the Contracting State : AT The use of a phosphate buffer system, which guarantees a pH value of 6.0-9.0, preferably of 7.5, and which has a phosphate concentration of 500-1000 mmol/l, preferably 1000 mmol/l, or of polyphosphate for the stabilization of interferon.
PH34356A 1985-10-15 1986-10-13 Stabilization of interferons PH22805A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH443385 1985-10-15

Publications (1)

Publication Number Publication Date
PH22805A true PH22805A (en) 1988-12-27

Family

ID=4276045

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34356A PH22805A (en) 1985-10-15 1986-10-13 Stabilization of interferons

Country Status (10)

Country Link
EP (1) EP0219073B1 (en)
JP (1) JPS6293300A (en)
AT (1) ATE50694T1 (en)
AU (1) AU591525B2 (en)
DE (1) DE3669263D1 (en)
DK (1) DK163280C (en)
IL (1) IL80288A0 (en)
NZ (1) NZ217885A (en)
PH (1) PH22805A (en)
ZA (1) ZA867747B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318685A (en) * 1987-08-18 1994-06-07 Cardinal Ig Company Method of making metal oxide films having barrier properties
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
FR2654343B1 (en) * 1989-11-10 1994-08-05 Roussel Uclaf USE OF A POLYPEPTIDE HAVING THE ACTIVITY OF INTERFERON GAMMA FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PRIMITIVE CANCERS OF THE FLEAVE.
JPH0771459B2 (en) * 1991-05-15 1995-08-02 三協食品工業株式会社 Functional food material and manufacturing method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA828580B (en) * 1981-12-23 1983-10-26 Schering Corp Interferon formulations
JPS6034919A (en) * 1983-08-04 1985-02-22 Green Cross Corp:The Gamma interferon composition
JPS61221129A (en) * 1985-03-25 1986-10-01 シエリング・コーポレーシヨン Stable gamma-interferon medicine

Also Published As

Publication number Publication date
DK488586A (en) 1987-04-16
AU6387286A (en) 1987-04-16
EP0219073B1 (en) 1990-03-07
ZA867747B (en) 1988-02-24
DK163280C (en) 1992-07-06
JPS6293300A (en) 1987-04-28
IL80288A0 (en) 1987-01-30
DK163280B (en) 1992-02-17
EP0219073A2 (en) 1987-04-22
DE3669263D1 (en) 1990-04-12
NZ217885A (en) 1989-06-28
EP0219073A3 (en) 1987-09-23
AU591525B2 (en) 1989-12-07
ATE50694T1 (en) 1990-03-15
DK488586D0 (en) 1986-10-13

Similar Documents

Publication Publication Date Title
DE3564157D1 (en) Equipment for the determination of the activity or concentration of ions in solutions
EP0190726A3 (en) Novel deoxyadenosine phosphate compounds and methods of making and using the same
EP0206810A3 (en) Acrylate compound and composition containing the same
EP0207158A4 (en) Anti-asthmatic composition containing 8,11,14,17-eicosatetraenoic acid.
IL76182A0 (en) Stabilization of elastomers with aliphatic-phenyldiamines and aliphatic phosphite compounds
GR3004556T3 (en)
ZA868155B (en) Stabilization of iron in aqueous systems
IL79699A0 (en) Antiviral compositions containing 2',3'-dideoxycytidine or its mono-or triphosphate
EP0219073A3 (en) Stabilization of interferons
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
NZ217178A (en) Determination of cyanamide in plant or plant parts
EP0227104A3 (en) Particles containing iron carbide
HUT43010A (en) Dispersions with increased sulfur content
GR3006357T3 (en)
GB2154406B (en) Port for graphitization furnace
GB8618598D0 (en) Ferrous sulphide
GR3007486T3 (en)
GB8503655D0 (en) Suspension of solids at high concentration
EP0197280A3 (en) Benzoyl ureas
EP0149977A3 (en) N-phosphoryl or n-thiophosphoryl-n'-s-triazinyl-formamidines
GB2190685B (en) Basic oxygen furnace steelmaking process
GB2191786B (en) Basic oxygen furnace steelmaking process
EP0161985A3 (en) 17-alpha-(aryloxy or alkoxy) androstenes
ZA848362B (en) Mixtures containing polyethylene thiuram disulfide and formaldehyde or paraformaldehyde
GB8427614D0 (en) Carbon disulphide copolymers